Mitsubishi Tanabe Pharma Corporation

714 papers and 16.1k indexed citations i.

About

In recent decades, authors affiliated with Mitsubishi Tanabe Pharma Corporation have published 714 papers, which have received a total of 16.1k indexed citations. Scholars at this organization have produced 286 papers in Molecular Biology, 105 papers in Endocrinology, Diabetes and Metabolism and 84 papers in Surgery on the topics of Diabetes Treatment and Management (76 papers), Pancreatic Islet Dysfunction and Regeneration (47 papers) and Pharmacogenetics and Drug Metabolism (40 papers). Their work is cited by papers focused on Molecular Biology (6.4k citations), Endocrinology, Diabetes and Metabolism (2.6k citations) and Surgery (1.8k citations). Authors at Mitsubishi Tanabe Pharma Corporation collaborate with scholars in Japan, United States and United Kingdom and have published in prestigious journals including Nature, Science and New England Journal of Medicine. Some of Mitsubishi Tanabe Pharma Corporation's most productive authors include Kenji Chiba, Kazuoki Kondo, Takashi Kadowaki, Yutaka Nakagawa, Nobuya Inagaki, Yasushi Kajii, Hiroaki Iijima, Toru Yoshinari, Nobuko Maruyama and Noriko Sato.

In The Last Decade

Fields of papers published by authors at Mitsubishi Tanabe Pharma Corporation

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Mitsubishi Tanabe Pharma Corporation at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Mitsubishi Tanabe Pharma Corporation at the time of their publication.

Countries citing scholars working at Mitsubishi Tanabe Pharma Corporation

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Mitsubishi Tanabe Pharma Corporation. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Mitsubishi Tanabe Pharma Corporation with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsubishi Tanabe Pharma Corporation more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025